Volume 17, Number 8—August 2011
Dispatch
Multidrug-Resistant Pandemic (H1N1) 2009 Infection in Immunocompetent Child
Table 2
Virus strain |
NA mutation |
Susceptibility | ||||
---|---|---|---|---|---|---|
OAHPP testing |
NML testing |
|||||
Mean IC50 ± SD, nmol |
-fold increase |
Mean IC50 ± SD, nmol |
-fold increase |
|||
A/Ontario/313762/2009 | I223R | 2.46 ± 0.30† | 12 | 6.84 ± 1.3† | 9 | |
A/California/07/2009-like control | Wild type | 0.20 ± 0.11‡ | 0.79 ± 0.45‡ | |||
Oseltamivir-resistant -control | H275Y | 0.20 ± 0.05§ | 0.76 ± 0.35§ |
*NA, neuraminidase; OAHPP, Ontario Agency for Health Protection and Promotion; NML, National Microbiology Laboratoy; IC50, 50% inhibitory concentration.
†For 7 and 4 experiments done by OAHPP and NML, respectively.
‡For 15 and 1,446 experiments done by OAHPP and NML, respectively.
§For 9 and 14 experiments done by OAHPP and NML, respectively.
Page created: August 15, 2011
Page updated: August 15, 2011
Page reviewed: August 15, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.